Trial Profile
Prophylactic Tamsulosin Use for Prevention of Post-Operative Urinary Retention
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 30 Jan 2019
Price :
$35
*
At a glance
- Drugs Tamsulosin (Primary)
- Indications Urinary retention
- Focus Therapeutic Use
- 21 Dec 2017 Status changed from recruiting to discontinued.
- 12 Jan 2017 Planned primary completion date changed from 1 Feb 2017 to 1 Feb 2018.
- 23 Feb 2016 New trial record